Sackler family expressed fears they could be targeted in lawsuits over OxyContin a DECADE before being sued for fueling the opioid crisis and transferring $10.7billion from their company Purdue Pharma Court filings unsealed Friday showed members of the Sackler family discussing potential future lawsuits over their role in the opioid crisis as far back as 2007 The family have long denied that the $10.7billion they transferred from Purdue Pharma was an unlawful attempt to shield assets in anticipation of litigation The significant transfers were made between 2008 and 2017 David Sackler, who served on Purdue's board from 2012 to 2018, testified in Congress last week that neither he, nor others, anticipated vast litigation